| OPMSX | VEXAX | OPMSX / VEXAX | |
| Total Expense Ratio | 1.04 | 0.05 | 2,080% |
| Annual Report Gross Expense Ratio | 1.04 | 0.05 | 2,080% |
| Fund Existence | 27 years | 26 years | - |
| Gain YTD | 9.290 | 13.067 | 71% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 3000 | 33% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.5B | 95.3B | 3% |
| Annual Yield % from dividends | 0.16 | 1.01 | 16% |
| Returns for 1 year | -0.36 | 12.28 | -3% |
| Returns for 3 years | 26.32 | 59.77 | 44% |
| Returns for 5 years | -2.50 | 27.88 | -9% |
| Returns for 10 years | 23.11 | 175.81 | 13% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| MSMR | 34.09 | 0.15 | +0.44% |
| McElhenny Sheffield Managed Risk ETF | |||
| MYHD | 24.77 | 0.04 | +0.18% |
| State Street®My2030 HighYield CrptBdETF | |||
| COPX | 88.53 | -0.08 | -0.09% |
| Global X Copper Miners ETF | |||
| PSQ | 25.93 | -0.23 | -0.88% |
| ProShares Short QQQ | |||
| BBC | 49.38 | -0.53 | -1.05% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||